Baidu
map

全国药政工作会议要求加强药品供应保障制度建设

2017-07-26 刘志勇 健康报

7月20日,2017年全国药政工作会议在京召开。国家卫生计生委主任李斌指出,药政工作必须坚持药品回归临床价值的理念,以药品供应保障制度建设为主线,进一步完善国家药物政策体系,推进体制机制改革创新,加强药学人才队伍建设,努力实现药品安全有效、供应充分、价格合理、使用科学。

7月20日,2017年全国药政工作会议在京召开。国家卫生计生委主任李斌指出,药政工作必须坚持药品回归临床价值的理念,以药品供应保障制度建设为主线,进一步完善国家药物政策体系,推进体制机制改革创新,加强药学人才队伍建设,努力实现药品安全有效、供应充分、价格合理、使用科学。

李斌指出,要进一步加强药品供应保障制度建设,以满足人民群众合理用药需求为导向,坚持药品回归临床应用、治病救人的初心本源;健全规范药品生产流通使用的关键政策,协调相关部门落实药品管理法律法规和“两票制”,整顿市场流通秩序,打击非法挂靠、过票等行为。系统防范药品廉政和质量“双风险”,紧盯腐败问题易发多发的重点环节,坚决惩治医药购销中的腐败行为;防范药品质量风险,严格执行药品采购诚信记录和市场清退制度,惩处药品质量安全不良行为记录企业,确保群众用药安全。

针对抓好药品供应保障制度建设的重点任务,李斌指出,要健全联动会商和分级应对机制,建立国家和省两级短缺药品清单,对清单内药品今年年底前全部纳入预警监测,开展临床综合评价、动态管理,建立全国短缺药品多源信息采集和供应业务协同应用平台。巩固完善国家基本药物制度,进一步提高使用比例,特别是二级以上医疗卫生机构的配备使用水平,鼓励地方为患结核病、糖尿病高血压等疾病的贫困人口免费提供部分基本药物。

李斌强调,要完善药品耗材集中采购政策和制度,坚持药品集中带量采购原则,鼓励跨区域和专科医院联合采购;加快推进高值医用耗材集中采购,今年各地要全部实施阳光采购。加快药品临床综合评价体系建设,加快评价结果在药物遴选、政策拟定、分类采购等方面的应用。强化医疗机构药学部门和药学人才队伍建设,科学核算、分类设置药事服务相关收费项目及标准。规范医疗卫生机构合理用药,重点研究制定基层医疗卫生机构药事管理规定,结合医联体建设,鼓励二级以上医疗机构药学部门加强对基层用药指导,促进基层与上级医院用药衔接。

国家卫生计生委副主任曾益新表示,国家卫生计生委此次高规格召开全国药政工作会议,在新一轮全面深化医改的历程中尚属首次,各地要充分认识到全面加强药政工作的必要性和紧迫性。当前药政工作还需解决一些突出问题,如巩固完善基本药物制度的内涵和具体政策措施;加快建立全国相对完整统一、成熟定型的药品供应保障制度,健全完善药政管理相关法律法规和制度机制。各地要抓准抓好临床使用、治病救人的终端环节,以此为切入点联动不同环节的政策,建立药品回归临床价值的长效机制。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1957521, encodeId=8f56195e52186, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Thu Oct 26 09:05:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028718, encodeId=85872028e18d0, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Aug 24 06:05:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716323, encodeId=2c401e16323a1, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Wed Nov 15 13:05:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226606, encodeId=3b34226606d3, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jul 26 17:56:47 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226583, encodeId=c165226583f4, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Jul 26 16:57:04 CST 2017, time=2017-07-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1957521, encodeId=8f56195e52186, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Thu Oct 26 09:05:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028718, encodeId=85872028e18d0, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Aug 24 06:05:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716323, encodeId=2c401e16323a1, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Wed Nov 15 13:05:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226606, encodeId=3b34226606d3, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jul 26 17:56:47 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226583, encodeId=c165226583f4, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Jul 26 16:57:04 CST 2017, time=2017-07-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1957521, encodeId=8f56195e52186, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Thu Oct 26 09:05:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028718, encodeId=85872028e18d0, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Aug 24 06:05:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716323, encodeId=2c401e16323a1, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Wed Nov 15 13:05:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226606, encodeId=3b34226606d3, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jul 26 17:56:47 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226583, encodeId=c165226583f4, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Jul 26 16:57:04 CST 2017, time=2017-07-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1957521, encodeId=8f56195e52186, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Thu Oct 26 09:05:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028718, encodeId=85872028e18d0, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Aug 24 06:05:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716323, encodeId=2c401e16323a1, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Wed Nov 15 13:05:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226606, encodeId=3b34226606d3, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jul 26 17:56:47 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226583, encodeId=c165226583f4, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Jul 26 16:57:04 CST 2017, time=2017-07-26, status=1, ipAttribution=)]
    2017-07-26 三生有幸9135

    学习一下谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1957521, encodeId=8f56195e52186, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Thu Oct 26 09:05:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028718, encodeId=85872028e18d0, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Aug 24 06:05:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716323, encodeId=2c401e16323a1, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Wed Nov 15 13:05:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226606, encodeId=3b34226606d3, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jul 26 17:56:47 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226583, encodeId=c165226583f4, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Jul 26 16:57:04 CST 2017, time=2017-07-26, status=1, ipAttribution=)]
    2017-07-26 中医痴

    不错的,学习了,谢谢分享!

    0

Baidu
map
Baidu
map
Baidu
map